Mobile Site ›

What the FDA Relabeling of Abacavir Means for You and Your Patient


Slide 3

November 2008

Abacavir is a nucleoside reverse transcriptase inhibiting of the human immunodeficiency virus. It is used in HAART therapy in combination with other anti-HIV drugs. It is marketed in the United States as Ziagen as a single drug, or as a fixed combination with other drugs and marketed as Epzicon and Trizivir.



Jump to section: